What is Bide Pharmatech Co., Ltd.'s (688073.SS) StockRank?

MoatMap's StockRank for Bide Pharmatech Co., Ltd. (688073.SS) is 57/100, with a Hold signal. This is a composite score combining Quality (67), Value (45), and Momentum (35) factor ranks across MoatMap's 19,000+ stock universe.

Does Bide Pharmatech Co., Ltd. have an economic moat?

Bide Pharmatech Co., Ltd. (688073.SS) has a Quality factor score of 67/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Bide Pharmatech Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Bide Pharmatech Co., Ltd. (688073.SS) is Hold, based on a StockRank of 57/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Bide Pharmatech Co., Ltd. in?

Bide Pharmatech Co., Ltd. (688073.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

688073.SS

HOLDREMOVE

Bide Pharmatech Co., Ltd. · Healthcare · China · $683M · Avg Vol: $10M/d

StockRank

P/E (TTM)

23.3x

ROE

8.1%

D/E

0.1x

Dividend %

2.5%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

While Bide Pharmatech operates in the life sciences reagent space, geopolitical tensions and potential Western legislative actions (e.g., the Biosecure Act) create a severe structural headwind for Chinese life science suppliers.

COMPANY DESCRIPTION

Bide Pharmatech Co., Ltd. provides life science research reagents, building blocks, and synthetic chemistry services for drug discovery. The company offers an extensive catalog of over 100,000 active compounds, serving as a critical supply chain partner for global pharmaceutical and biotechnology firms. It is a leading niche provider of laboratory-scale chemical reagents with highly efficient logistics and inventory management.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	123M	161M	163M	196M	16.7%
EPS	0.29	0.18	0.20	0.26	-4.0%
Shares	91M	91M	91M	91M	0.0%
Debt	6M	8M	12M	21M	51.2%
Equity	307M	309M	300M	302M	-0.5%
Op CF	4M	-8M	23M	4M	-1.8%
Inv CF	-6M	-4M	-23M	-11M	—
Fin CF	194M	-20M	-25M	-20M	—

PRICE (1M)-27.3%

SMA 50SMA 200

$6.62

RSI (14)

17.4

52W High

$11.95

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

9.3%71.2

ROE

8.1%66.4

GP/Assets

23.0%52.6

Op. Margin

23.9%87.4

FCF/Assets

-0.8%47.5

Piotroski

—55.8

Int. Cover

34.7x79.8

D/E Ratio

0.06x71.7

Current Ratio

7.43x81.3

Value

P/E (TTM)

23.3x49.1

EV/EBITDA

13.3x32.1

P/FCF

—N/A

P/B

1.9x58.5

P/S

3.0x56.7

Div Yield

2.5%59.1

Momentum

52W High %

55%31.4

RS 6M

-43%27.2

SMA 50/200

0.88x26.9

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

53%77.3

FUNDAMENTALS

Market Cap

$683M

P/E (Forward)

—

Gross Margin

42.7%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 688073.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
688073.SS	Bide Pharmatech Co., Ltd.(you)	$683M	57	HOLD
301393.SZ	Suzhou Highfine Biotech Co., Ltd.	$896M	55	HOLD
688566.SS	Jiangsu Jibeier Pharmaceutical Co., Ltd.	$741M	65	BUY
300401.SZ	Zhejiang Garden Biopharmaceutical Co.,Ltd.	$984M	54	HOLD
300119.SZ	Tianjin Ringpu Bio-Technology Co.,Ltd.	$1.1B	55	HOLD
688117.SS	ChengDu ShengNuo Biotec Co.,Ltd.	$785M	48	HOLD
600829.SS	HPGC Renmintongtai Pharmaceutical Corporation	$746M	46	HOLD
2186.HK	Luye Pharma Group Ltd.	$1.1B	61	HOLD
688799.SS	Hunan Warrant Pharmaceutical Co.,Ltd	$975M	50	HOLD
300194.SZ	Fuan Pharmaceutical (Group) Co., Ltd.	$672M	43	HOLD

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.1%

Bide Pharmatech Co., Ltd. (688073.SS) — Stock Score Summary

Bide Pharmatech Co., Ltd. (688073.SS) has a MoatMap StockRank of 57/100 based on Quality (67/100), Value (45/100), and Momentum (35/100) factor scores. The current signal is HOLD. While Bide Pharmatech operates in the life sciences reagent space, geopolitical tensions and potential Western legislative actions (e.g., the Biosecure Act) create a severe structural headwind for Chinese life science suppliers.

Key Financial Metrics

Price	$6.62
Market Cap	$683M
P/E (TTM)	23.27
Price/Book	1.86
Return on Equity	8.1%
Return on Invested Capital	9.3%
Debt/Equity	6.45
Gross Margin	42.7%
Operating Margin	23.9%
Revenue Growth	9.1%
Dividend Yield	2.5%
Free Cash Flow	$-460K

Bide Pharmatech Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Bide Pharmatech Co., Ltd.’s (688073.SS) StockRank?: MoatMap’s StockRank for Bide Pharmatech Co., Ltd. (688073.SS) is 57/100, with a Hold signal. It is a composite of Quality (67), Value (45), and Momentum (35) factor ranks across MoatMap’s 19,000+ stock universe.
Does Bide Pharmatech Co., Ltd. have an economic moat?: Bide Pharmatech Co., Ltd. (688073.SS) has a Quality factor score of 67/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Bide Pharmatech Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Bide Pharmatech Co., Ltd. (688073.SS) is Hold, based on a StockRank of 57/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Bide Pharmatech Co., Ltd. in?: Bide Pharmatech Co., Ltd. (688073.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).